(Q37762995)

22 August 2017

1 reference

title

FGF23 and the parathyroid glands (English)

1 reference

22 August 2017

Justin Silver

1

1 reference

PubMed ID

20526631

22 August 2017

Tally Naveh-Many

series ordinal

2

1 reference

22 August 2017

5 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

25

1 reference

22 August 2017

11

1 reference

22 August 2017

2241-2245

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-010-1565-3

22 August 2017

0 references

cites work

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

1 reference

12 December 2020

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

1 reference

12 December 2020

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

12 December 2020

Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

1 reference

12 December 2020

Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.

1 reference

12 December 2020

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

12 December 2020

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

12 December 2020

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

1 reference

12 December 2020

Endocrine functions of bone in mineral metabolism regulation.

1 reference

12 December 2020

Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?

1 reference

12 December 2020

Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia

1 reference

12 December 2020

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

1 reference

12 December 2020

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

1 reference

12 December 2020

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

1 reference

12 December 2020

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

1 reference

12 December 2020

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

1 reference

12 December 2020

Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane

1 reference

12 December 2020

Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression

1 reference

12 December 2020

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

1 reference

12 December 2020

Do osteocytes contribute to phosphate homeostasis?

1 reference

12 December 2020

Human PTH gene regulation in vivo using transgenic mice.

1 reference

12 December 2020

Klotho prevents renal calcium loss.

1 reference

12 December 2020

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.

1 reference

12 December 2020

Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin

1 reference

12 December 2020

Regulation of fibroblast growth factor-23 signaling by klotho

1 reference

12 December 2020

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

1 reference

12 December 2020

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

1 reference

12 December 2020

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

12 December 2020

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

12 December 2020

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

1 reference

12 December 2020

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

12 December 2020

Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway

1 reference

12 December 2020

FGF23-parathyroid interaction: implications in chronic kidney disease

1 reference

12 December 2020

Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

10.1007/S00467-010-1565-3

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20526631